FTC Releases Second Interim Staff Report on Prescription Drug …
1 day ago · “FTC staff have found that the Big 3 PBMs are charging enormous markups on dozens of lifesaving drugs,” said Hannah Garden-Monheit, Director of the FTC’s Office of Policy Planning. “We also found that this problem is growing at an alarming rate, which means there is an urgent need for policymakers to address it.”
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
Sep 20, 2024 · The FTC alleges that the three PBMs created a perverse drug rebate system that prioritizes high rebates from drug manufacturers, leading to artificially inflated insulin list prices.
FTC Releases Interim Staff Report on Prescription Drug Middlemen
The Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
FTC alleges PBMs cost consumers $7.3 billion marking up drug …
1 day ago · The Federal Trade Commission (FTC) released a 60-page report Tuesday targeting the three biggest pharmacy benefit managers (PBMs), claiming the companies hiked the prices of specialty drugs by ...
Top three insurers reaped $7.3 billion through their drug ... - NBC …
1 day ago · Three days later, the FTC sued Express Scripts and the other two top PBMs, alleging anticompetitive practices that artificially inflated insulin prices. All three companies have disputed those ...
FTC doubles down on PBM criticism in new report
12 hours ago · The FTC's first report drew a strong response from the PBM sector, with lawsuits filed in both directions. The FTC has accused the big three of operating a "perverse drug rebate system," while the ...
PBMs made billions marking up specialty drugs by more than …
1 day ago · The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through ...
FTC finds middlemen inflate specialty generic drug prices by …
1 day ago · The FTC’s investigation into PBM practices began in 2022. Last summer, the agency released a scathing interim report on the industry. It detailed how increasing concentration enabled the three ...
PBMs made more than $7B marking up specialty generics: FTC
1 day ago · What they found: The PBMs marked up prices for specialty generic drugs by hundreds and sometimes thousands of percent over their estimated acquisition costs from 2017 and 2022, per the FTC report. Most of the highly-marked up drugs were dispensed at pharmacies affiliated with the PBMs.
FTC Report Reveals PBM Practices Impacting Competition and …
8 hours ago · The FTC found that from 2017 to 2022, the three big PBMs imposed substantial price markups on 51 specialty generic drugs, resulting in $7.3 billion in excess revenue.The report highlighted that ...